{"url_path":"/sec/sxtc/10-k/2026/item-16a","section_key":"item-16a","section_title":"Item 16A AUDIT COMMITTEE","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","accession_number":"0001213900-26-074310","cik":"0001723980","ticker":"SXTC","issuer_name":"China SXT Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","primary_entity_key":"0001723980","primary_entity_name":"China SXT Pharmaceuticals, Inc."},"word_count":94,"has_tables":true,"body_markdown":"ITEM 16A. AUDIT COMMITTEE\nFINANCIAL EXPERT\n\n \n\nMr. Yong Lip Chee, Mr. Tong\nLiu and Mr. Xiaodong Ji are members of our Audit Committee, where Mr. Yong Lip Chee, serves as the chairman. All proposed members of\nour Audit Committee satisfy the independence standards promulgated by the SEC and by NASDAQ as such standards apply specifically to members\nof audit committees. It is determined that Mr. Yong Lip Chee, possesses accounting or related financial management experience that qualifies\nhim as an “audit committee financial expert” as defined by the rules and regulations of the SEC."}